Open in interactive viewer → charts, metric popovers & call review

Karman: Record Quarters, Second-Source Offense, and a Stock That's Still Falling

The defense supplier delivered record revenue and a $1.3B backlog, but the market remains unconvinced. Inside the disconnect.
KRMN · Earnings Call · 2026-08-06

Karman: Record Quarters, Second-Source Offense, and a Stock That's Still Falling

Karman Holdings (KRMN) reported a second-quarter that most defense suppliers would envy: revenue of $182M, adjusted EBITDA of $55M, and a record $1.3B backlog. Organic growth accelerated to 24.4% year-over-year, and management lifted full-year guidance. Yet the stock is down 53% from its January peak, and even a 15% bounce off the bottom leaves it 35% below the 90-day high. The disconnect between operational strength and market sentiment is the real story.

A Quarter That Beat the Odds

CEO Jonathan Rambeau framed the quarter as confirmation of a structural inflection: “some customers are now citing demand to increase certain annual production buys by as much as a factor of 10x” — Jonathan Rambeau, Chief Executive Officer · 2026-08-06. That demand is translating into bookings—nearly $500M in the quarter, mostly for 2027 and beyond. The company also secured a 5-year LTA with a space and launch customer, adding a long-term revenue floor.

The standout theme, however, is the second source opportunity. As primes like Lockheed and the Navy award massive contracts, Karman is positioning itself to take share from undercapitalized suppliers. Rambeau was direct: “I would call it a net opportunity for Karman” — Jonathan Rambeau, Chief Executive Officer · 2026-08-06, citing specific wins—separation motors, a second-source on a small propulsion system, and a potential shroud system for a major interceptor. This is a genuine strategic pivot, one that was only hinted at in prior quarters. On the May call, he said customers were “coming forward with these requests for longer term ramps” — Jonathan Rambeau, Chief Executive Officer · 2026-05-12; now that demand is becoming concrete.

The Organic Growth Question

Management also made a deliberate move to de-emphasize quarterly organic growth, arguing that integration-driven revenue is real value creation. The company reiterated its 20-25% organic growth target and sees 25%+ for 2026, but the optics are delicate. CFO Michael Willis noted: “We expect volume and cash generation to accelerate in the second half of 26” — Michael Willis, Chief Financial Officer · 2026-08-06. That's a pledge to convert growth into cash—something investors are waiting on, given negative free cash flow and a 3.7x leverage ratio.

The demand environment remains strong with an urgency to replenish depleted munitions and interceptor stockpiles at an unprecedented rate.

Jonathan Rambeau, Chief Executive Officer · 2026-08-06

Cash Flow and the Leverage Overhang

The financial story is more nuanced than the headline numbers suggest. Free cash flow (less SBC) was -$7M in the quarter, pulled down by working capital investments to support the ramp. The company is guiding to $15-20M of FCF in H2, but that's a thin margin against a $750M+ net debt position. Management is aware—they've added free cash flow to executive comp starting in 2027. The +51% revenue growth is impressive, but the cash conversion is the market's sticking point.

The Market's Skepticism

Despite the operational beat, the stock has been in a drawn-out decline, now down 53% from its January peak. The tape shows a 12-week down leg before a recent 8-week bounce. This isn't a reaction to missed numbers; it's a re-rating. The market is asking whether Karman can sustain growth while paying down leverage—and whether the organic revenue narrative holds up when acquisitions carry a large chunk of the growth. Analysts on the call pressed exactly this, and management's answer was confidence in the 20-25% organic growth trajectory, backed by record backlog and generational demand.

The strategic moves—Walker Precision Engineering, the new LTA, the second-source push—are all accretive to the long-term story. But with the stock in a deep drawdown and free cash flow still negative, the wait for validation is real. As prior calls showed, management had previously downplayed second sourcing risk; now they've embraced it as an offensive weapon. That's a genuine change in posture, and it's why the market should be paying attention—even if the price action says otherwise.